Health & social careAward notice🇪🇸 SpainPLACSP

ta2026 lote114 - atezolizumab - tecentriq - derivado del am 27/2022 de medicamentos exclusivos del sermas - hito 1- hcd

Inspección General de Sanidad de la Defensa

Estimated value

€96.2k

Awarded value

€96.2k

Published 15 Dec 2025

Contract type: Supplies
Procedure: Other single-stage procedure
Main CPV: 33000000
Regions: ES300
Language: SPA

Envelope AESPD (DEUC), signed
PCAP, p. 4
Envelope ATurnover at least 1.5 × the contract value
PCAP, p. 7
Envelope BTechnical report, max. 20 pages
PCAP, p. 15
Envelope CEconomic offer in the Annex II model
PCAP, Anexo II

Envelope B · Technical report

2. Methodology and work plan

The service is organised in three phases matching the award sub-criteria 2.1–2.3, with a named team lead and weekly reporting to the contracting authority.

Phase 1: start-up and handover (weeks 1–4)
Quality plan under ISO 9001

Page 4 of 18 · limit 20

Example

Prepare the bid with the assistant Pro

The bid assistant reads the tender's documents, lists exactly what they require and drafts the bid with your team. Included in Pro, with monthly bid credits.

Every requirement with its page and quote
A checklist for the team
Technical report and declarations drafted
Word and PDF per envelope

Looking for partners

Nobody has declared interest yet.

Awarded to

ROCHE FARMA S.A. (Spain) — €96,154 · 1 tenders received

View on PLACSP

How to read this noticeWhat each part of a notice tells you and what to check first.

ta2026 lote114 - atezolizumab - tecentriq - derivado del am 27/2022 de medicamentos exclusivos del sermas - hito 1- hcd

Prepare the bid with the assistant Pro

Awarded to

ta2026 lote114 - atezolizumab - tecentriq - derivado del am 27/2022 de medicamentos exclusivos del sermas - hito 1- hcd

Prepare the bid with the assistant Pro

Looking for partners

Awarded to

Where

Explore

Looking for partners